FTSE slides on oil

clock

The FTSE 100 Index fell 0.33% to 6,004.70 points today, led by losses among oil heavyweights, Tate & Lyle and GlaxoSmithKline.

BP fell 1.48% to 664.50p, Shell dropped 0.42% to 1,886p and BG declined 0.41% to 725.50p after Goldman Sachs cut estimates across the sector and May crude drifted back 74 cents a barrel to $66 in US trade. GlaxoSmithKline fell 1.51% to 1,500p after it was downgraded to "neutral" from "buy" at UBS following disappointing results for Advair. Tate & Lyle also dropped 1.91% to 564.50p as a consumer advocates group in the US suggested its Splenda sweetener could cause digestion problems. Meanwhile, Severn Trent gained 6.31% to 1,197p after it announced it is to demerge its Biffa waste-disp...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Partner Insight: Debt, deficits, and market resilience: Is your portfolio prepared?

Partner Insight: Debt, deficits, and market resilience: Is your portfolio prepared?

The world is awash in debt. In the US, government borrowing has surged past 100% of GDP, and the fiscal deficit is at a level typically seen in wartime. Other major economies are in similar situations. So, what does this deluge of debt mean for markets?

Orbis Investments
clock 19 May 2025 • 5 min read
Three Invesco funds fail to deliver value to investors

Three Invesco funds fail to deliver value to investors

Manager's annual assessment found some poor performance

clock 14 May 2025 • 2 min read
Darius McDermott: Old demographics, new innovations — so why isn't healthcare booming?

Darius McDermott: Old demographics, new innovations — so why isn't healthcare booming?

'The sector should be flying — but it isn't'

Darius McDermott
clock 08 May 2025 • 5 min read